Findings in Cytomegalovirus Reported from University Peruana Cayetano Heredia (Refractory human cytomegalovirus infection without evidence of genetic resistance in the UL-54 and UL-97 genes in a pediatric hematopoietic stem cell transplant...).

A recent report from the University Peruana Cayetano Heredia in Lima, Peru discusses the case of a pediatric patient who developed a refractory cytomegalovirus (CMV) infection after undergoing a hematopoietic stem cell transplant (HSCT). Despite treatment with multiple antiviral drugs, the patient's infection did not respond. Genetic testing ruled out resistance to the first-line treatment. This case highlights the challenges of managing refractory CMV infections, especially in developing countries with limited access to alternative treatments. The researchers emphasize the importance of using sensitive genetic tools to detect mutations associated with drug resistance. [Extracted from the article]

Copyright of Stem Cell Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)